Private company evaluation
Private company evaluation against public market evidence
A private business has no share price and no consensus estimates, which is why most private company valuation ends in a rule of thumb. NeuraCap replaces the rule of thumb with evidence: you provide the figures, and the platform positions them against listed peers, precedent transactions and sector benchmarks that are public and checkable.
- Public peer benchmarks
- Precedent transactions
- Percentile positioning
- Football field range
The story
You know your numbers. The market decides what they are worth.
Private company evaluation
Your figures, read against public evidence
- The problem
- Owners, boards and investors in private businesses are asked what the company is worth and have nothing to point at. The available answers are a multiple somebody once heard, or a process that takes weeks and costs more than the question.
- Why it matters
- The number decides what a shareholder is offered, what an acquirer will argue for, what a lender will lend against and whether a transaction is worth starting at all. A figure with no evidence behind it collapses the first time it is tested.
- In NeuraCap
- You provide the financials and operating detail. NeuraCap structures them, builds a listed peer set on business model and financial profile, pulls normalised precedent transactions in the same space, ranks the company against the peer distribution, and assembles the methods.
- What you get
- A percentile position on growth, margin, returns and cash conversion; the peer and transaction multiples that apply; and a football-field range with a stated primary basis and EV/Revenue as a cross-check.
- The decision it enables
- Whether to sell, raise, buy or wait — and, if the answer is sell, what the range should be and which part of the business would have to change to move it.
You provide
User-provided data, structured and enriched.
- Revenue, gross profit, EBITDA and the periods behind them
- Cost structure and the split between fixed and variable
- Customer concentration, contract length and revenue quality
- Headcount, capacity and the operating measures you already track
- Balance sheet: debt, cash, working capital and any adjustments
- What the business does, where it sells, and to whom
NeuraCap brings
Public evidence and calculated benchmarks.
- A public peer set chosen on business model and financial profile
- Trading multiples for that peer set, trailing and on consensus estimates
- Precedent transactions in the same space, normalised for comparison
- Sector growth, margin and multiple benchmarks over your chosen window
- Medians and percentile bands rather than a single headline average
- A written read on where the business sits and what would move it
How it works
Five steps from your accounts to a defensible range.
Your figures, structured
The numbers you supply are put into the same structure NeuraCap uses for listed companies, so the comparison is like for like rather than approximate. This is user-provided data, enriched — it is not derived from filings, and the platform never presents it as though it were.
A peer set from the public market
The business is matched to listed companies that make money the same way at a comparable scale and growth rate. Those companies supply the multiples, the margin structure and the KPI distribution that private businesses have no direct equivalent for.
The transaction record
Private businesses change hands at transaction multiples, not trading multiples. Precedent deals in the same space are normalised and read alongside the public comparables, which is usually where the interesting gap appears.
Position, then value
The company is ranked against the peer distribution on growth, margin, returns and cash conversion before any multiple is applied, because the percentile is the argument for where in the range the business should sit.
A range with a stated basis
Methods are assembled onto the football field with a stated primary valuation basis for the sector and EV/Revenue as a cross-check, and with the reason each method lands where it does.
Provenance
Which part of the analysis came from where.
User-provided and enriched
Everything about the private business itself comes from you. NeuraCap structures and enriches it; it does not verify your accounts, and it never labels your figures as filed or audited data.
Public and checkable
The benchmark context is public: fundamentals from SEC EDGAR filings where applicable, consensus estimates, market price data and a structured M&A transaction record. See the coverage and data page.
Calculated and interpreted
Multiples, medians and percentiles are calculated. The narrative around them is AI-assisted interpretation, phrased as a reading of the evidence rather than as asserted cause and effect.
Limits
What this evaluation is not.
- It is not an appraisal and not a fairness opinion.
- It is not a recommendation to buy or sell a security, nor an offer or solicitation.
- It does not audit, verify or attest to the figures you provide.
- No fiduciary relationship is created by using the platform.
- The output is a market-evidence view of value. A transaction price depends on the process, the buyer and the terms, and can sit outside any evidence-based range.
Handling of the material you upload is described on the security page. Where a transaction needs a person accountable for the conclusion, NeuraCap advisory works from the same evidence base.
Proof
See it in the published research.
Your sector’s benchmarks
Find the industry group your business sits in and read the published spread. See the sectors we cover.
Who is buying
The deal record shows which acquirers are active and at what multiples, through M&A intelligence.
The finished deliverable
A private evaluation arrives as a report you can take to a board. See what a company report contains.
Find out what your business is worth on today's evidence.
Tell us the company and what you need to understand. Public or private, any sector.